Other
Unrealized Gain (Loss) on Derivatives, Net
West Pharmaceutical Services Unrealized Gain (Loss) on Derivatives, Net increased by 35.3% to -$1.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 164.7%, from $1.70M to -$1.10M.
Analysis
StatementIncome Statement
SectionOther
CategoryRisk
SignalContext dependent
VolatilityVolatile
First reportedQ3 2023
Last reportedQ1 2026Apr 23, 2026
How to read this metric
An increase indicates favorable market movements on hedging positions, while a decrease suggests unfavorable valuation changes.
Detailed definition
Represents the change in fair value of derivative financial instruments designated as hedging instruments that has not y...
Peer comparison
Commonly reported by industrial and energy firms using derivatives to manage commodity or currency risk.
Metric ID:
pfe_unrealized_gain_loss_derivativesHistorical Data
8 periods
| Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|
| Value | -$2.00M | -$2.80M | -$3.70M | $5.50M | $1.70M | $2.20M | -$1.70M | -$1.10M |
| QoQ Change | — | -40.0% | -32.1% | +248.6% | -69.1% | +29.4% | -177.3% | +35.3% |
| YoY Change | — | — | — | +375.0% | +160.7% | +159.5% | -130.9% | -164.7% |
Range-$3.70M – $5.50M
CAGR-28.9%
Avg YoY Growth+79.9%
Median YoY Growth+159.5%
Unrealized Gain (Loss) on Derivatives, Net at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's unrealized gain (loss) on derivatives, net?
- West Pharmaceutical Services (WST) reported unrealized gain (loss) on derivatives, net of -$1.10M in Q1 2026.
- How has West Pharmaceutical Services's unrealized gain (loss) on derivatives, net changed year-over-year?
- West Pharmaceutical Services's unrealized gain (loss) on derivatives, net decreased by 164.7% year-over-year, from $1.70M to -$1.10M.
- What does unrealized gain (loss) on derivatives, net mean?
- The change in value of open derivative hedging contracts that has not yet been realized.